![Thibaut du Fayet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thibaut du Fayet
Algemeen Directeur bij
PHAXIAM THERAPEUTICS S.A.
Profiel
Thibaut du Fayet is currently the Chief Executive Officer at PHAXIAM Therapeutics SA since 2023.
Previously, he worked as the Deputy Chief Executive Officer at Pherecydes Pharma SA in 2022, Director-Marketing & Strategy at bioMérieux SA, Director at Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd., and Vice President-Business Development & Marketing at Transgene SA from 2008 to 2013.
He also worked as the Head-Marketing at Stallergenes SA from 2007 to 2008.
Mr. du Fayet holds a graduate degree from Brandeis University and an MBA from ESSEC Business School, which he received in 1992.
Actieve functies van Thibaut du Fayet
| Bedrijven | Functie | Begin |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Algemeen Directeur | 23-06-2023 |
Eerdere bekende functies van Thibaut du Fayet
| Bedrijven | Functie | Einde |
|---|---|---|
| STALLERGENES | Verkoop & Marketing | 01-01-2008 |
| BIOMÉRIEUX | Verkoop & Marketing | - |
| PHERECYDES PHARMA | Algemeen Directeur | - |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
 Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and manufactures immunotherapies for the treatment of oncology and infectious diseases | Directeur/Bestuurslid | - |
| TRANSGENE | Corporate Officer/Principal | - |
Opleiding van Thibaut du Fayet
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
22
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and manufactures immunotherapies for the treatment of oncology and infectious diseases | Commercial Services |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
